SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055082
Filing Date
2024-05-08
Accepted
2024-05-08 08:04:18
Documents
53
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlis-20240331.htm   iXBRL 10-Q 974730
2 EX-10.3 tlis-ex10_3.htm EX-10.3 12110
3 EX-31.1 tlis-ex31_1.htm EX-31.1 15466
4 EX-31.2 tlis-ex31_2.htm EX-31.2 16482
5 EX-32.1 tlis-ex32_1.htm EX-32.1 9471
6 EX-32.2 tlis-ex32_2.htm EX-32.2 10462
  Complete submission text file 0000950170-24-055082.txt   4723440

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20240331.xsd EX-101.SCH 911323
56 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20240331_htm.xml XML 629509
Mailing Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065
Business Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40047 | Film No.: 24924319
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)